Groowe / Newsroom / NRXP

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NRXP News

NRX Pharmaceuticals, Inc. Common Stock

New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

accessnewswire.com Sep 24, 2025 3:25 PM